Natrecor Concerns Are Limiting Use Of Other IV Vasoactive Therapies As Well, JAMA Finds
This article was originally published in The Pink Sheet Daily
Executive Summary
Decline in use of other congestive heart failure therapies raises concerns about the effect of articles that question the safety of approved medications.